Integrated Diagnostics Holdings PLC (CHIX:IDHCl)
$ 0.50 (0%) Market Cap: 291.83 Mil Enterprise Value: 297.24 Mil PE Ratio: 31.38 PB Ratio: 4.11 GF Score: 59/100

Half Year 2025 Integrated Diagnostics Holdings PLC Earnings Call Transcript

Sep 15, 2025 / 12:00PM GMT
Release Date Price: $0.58 (+3.57%)

Key Points

Positve
  • Integrated Diagnostics Holdings PLC (IDGXF) reported a 42% increase in consolidated revenue for the first half of 2025, reaching EGP3.5 billion.
  • The company achieved a significant improvement in profitability, with gross profit margin expanding by 5 percentage points and adjusted EBITDA margin by 7 percentage points compared to the previous year.
  • The Board of Directors approved a cash dividend distribution of $0.017 per share, reflecting strong financial performance and robust liquidity.
  • The company successfully expanded its operations, opening 49 new locations in Egypt and achieving a 9% increase in test volumes and a 3% rise in patient volumes year-on-year.
  • The house call service in Egypt contributed to 20% of revenues, demonstrating successful strategic investments and growth in patient touchpoints.
Negative
  • Operations in Sudan remain significantly impacted by ongoing conflict, with no notable updates reported.
  • The company faces inflationary pressures in key markets, although proactive cost control efforts are mitigating some of these effects.
  • Some costs are linked to the dollar, particularly raw material expenses, which could be affected by currency fluctuations.
  • Despite strong overall performance, the company anticipates a potential slowdown in the second half of the year due to increased investments and costs.
  • The company is still working on optimizing costs and improving efficiencies, indicating ongoing challenges in maintaining operational efficiency.
Ahmed Moataz
EFG Hermes Securities Brokerage Co - Analyst

Hello, everyone. This is Ahmed Moataz from EFG Hermes, and welcome to IDH's first half of '25 results conference call. I'm pleased to be joined with Dr. Hend El Sherbini, Chief Executive Officer; Sherif El Zeiny, Chief Financial Officer; and Tarek Yehia, Director of Investor Relations. As usual, the company will start with a brief presentation, and then we'll open for Q&A. IDH, please go ahead.

Tarek Yehia
Integrated Diagnostics Holdings PLC - Investor Relations Director

Good afternoon, ladies and gentlemen, and thank you, Ahmed, and thank you, everyone, for joining us for IDH second quarter analyst call. My name is Tarek Yehia, am I am HR -- IDH Investor Relations Director. Joining me today, we have Dr. Hend El Sherbini, our CEO; Mr. Sherif El Zeiny, our CFO. Dr. Hend will begin the call with a summary of the latest period main highlights.

After that, I will discuss in more details the main macro-economic and geopolitical trends seen across our market. Mr. Sherif will offer a deeper

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot